Featured Articles

Subscribe to this site 

Tags:



No Comments

Using DuPont Analysis to look at DuPont

By Samuel Toba - Last updated: Thursday, February 4, 2010

Why are companies announcing profitability while undertaking cost cutting measures? Return On Equity (ROE) is a widely used indicator of profitability and potential growth. A higher ROE generates a higher value for its shareholders. DuPont expanded the ROE and created the DuPont Analysis. This month, we discuss how you can use the DuPont Analysis to better understand a company’s financial report.

Read More...

Tags:



2 Comments

Chemists at Heart – Valentine 2010

By Samuel Toba - Last updated: Monday, February 1, 2010

In celebration of Valentine 2010, below are selected stories received from chemists on how they met their special someone through chemistry. Thank you to all who shared their personal stories.

Read More...

Tags:



No Comments

How to Grow Your Small Business into a Large Corporation – The Story of SAIC and the Secret Sauce of Employee Ownership

By Samuel Toba - Last updated: Thursday, January 21, 2010

Want to learn the secret to growing your business by empowering your employees? Employee ownership – giving employees a stake in the growing value of their company – has been validated repeatedly as a strategy that gives companies a real competitive edge. Of course, the concept is fairly simple. But how does it actually work? Join us to learn how small and medium sized companies, and their employees, can create a system of employee ownership that is tailored expressly for their individual needs. We will also learn how SAIC has used the employee-owned model to grow from a small technology company into an $8B powerhouse.

Read More...

Tags:



No Comments

Staying ahead of the game: Recent innovations in computational methods for drug discovery

By Samuel Toba - Last updated: Thursday, January 21, 2010

Looking for new ideas in your research projects? Want to know if computational methods can help? Knowing when to use a certain tool in your research is as crucial as deciding whether you should use it. Advances in computational methods have greatly sped up drug discovery, but it is not without its setbacks. Our speaker will discuss the successes of computational modeling and how to benefit from failures and avoid costly mistakes. Join us as we probe the secrets of when to deploy computational methods and how to get the innovations you want.

Read More...

Tags:



No Comments

Developing Career Skills to Compete in a Global Economy – Observations of AMRI Operations in India, Singapore, Hungary and the United States

By Samuel Toba - Last updated: Thursday, January 21, 2010

Do you know how your skills compare to scientists from other countries? Would you like to learn how to stay competitive in the integrated global economy? The global business landscape for chemistry has changed and scientists must adapt. Our speaker will share his observations of R&D operations in several countries. Join us to learn how you can develop your career skills and be competitive in this global era.

Read More...

Tags:



No Comments

Online Monitoring for Water and Wastewater Processes – Global Sustainability at Your Fingertips

By Samuel Toba - Last updated: Thursday, January 21, 2010

Do you know that the global market for water treatment products is a $44 Billion industry? The spending and needs for products and experts in this field is expected to grow with the escalation in global water demand and consumption. If you are interested in learning about the latest in online monitoring equipment, how to meet water regulatory requirements for your company, or to discuss new opportunities in the area of global sustainability, you can not afford to miss this seminar. Join us to explore the latest trends in technology and learn best practises for online water monitoring.

Read More...



3 Comments

Executive View – How should a chemical company measure risk when evaluating investment opportunities? Part 2 of 2.

By Samuel Toba - Last updated: Thursday, January 7, 2010

The Four Valleys question. Do you work for a ‘Napa Valley’ kind of business? Is it in ‘Happy Valley’? Or could it be heading for ‘Death Valley’? Last month, we looked at strategic risk – how a company might evaluate different growth opportunities by using the Ansoff Matrix. This month, we look at how a company can manage operational risk, using the Four Valleys matrix; matching its culture and ways of working to the markets in which it operates.

Read More...

Tags:



No Comments

East Meets West: Global Opportunities in Asia Pacific

By Samuel Toba - Last updated: Wednesday, January 6, 2010

Eager to tap into career and business opportunities in China? China is rapidly transforming itself into a high tech powerhouse. Increasing number of companies are setting up R&D centers in China. While China may offer many career and business opportunities, one needs to learn about the political and cultural landscape to successfully capitalizeon the country’s dynamic growth. Learn from our speaker how to scientists and businesses can capitalize on their Eastern and Western strengths. Join us to explore the opportunities that may be waiting for you in the Far East.

Read More...

Tags:



No Comments

Failure is an Option: Learn How to Turn Failure into an Advantage

By Samuel Toba - Last updated: Tuesday, December 15, 2009

We are all familiar with failures and yet failures carry a negative stigma to both individuals and companies. Just as the phoenix can rise from the ashes, successful individuals and companies are those who have successfully turned failures into advantages. Join us to learn from our speaker the art of calculating risks and taking charge of setbacks. You too can turn failures into success.

Read More...



2 Comments

Executive View – How should a chemical company measure risk when evaluating investment opportunities? Part 1 of 2.

By Samuel Toba - Last updated: Wednesday, December 2, 2009

Ever wonder how your company’s executives make their decisions in this recession? Difficult times, such as today’s, require companies to pay close attention to the risk element when considering any investment. Consider the recent mergers in basic chemicals for Dow Chemicals and Rohm & Haas, in pharmaceuticals for Pfizer and Wyeth, and the recent bid from Reliance for chemical giant Lyondell-Basell. Luckily, there are some standard tools available for helping with this process.

Read More...